HOOK
HOOKIPA Pharma Inc.Company Information
- Company Name
- HOOKIPA Pharma Inc.
- CIK
- CIK0001760542
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- HOOK: OTC
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- HOOK
SEC filing data through
Insider Sentiment
- Last purchase
- 2023-08-21
- Last sale
- 2025-08-19
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 67,957
Institutional Sentiment
- As of
- 2025-06-30
- Institutional shares owned
- 4,233,015
- Shares outstanding
- 12,544,777
- Ownership
- 33.74%
Earnings Market Reaction
- Filing date
- 2025-05-15
- Price on filing date
- —
- 1-month reaction
- 7.59%
- 3-month reaction
- -38.94%
Balance Sheet
Values in millions ($)| Line item | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock Other Than Class | 10 | 10 | 0 | 0 | 10 | 10 | 0 | -44 | 52 | 52 | 1 | 0 | ||||||
| Series1 Convertible Preferred Stock | - | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | ||||||
| Common Class A | 2 | 2 | 0 | 0 | 2 | 2 | 0 | 0 | 2 | 2 | -1 | 0 | ||||||
Assets | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 40 | 40 | 60 | 77 | 93 | 117 | 108 | 136 | 110 | 112 | 100 | 118 | ||||||
| Restricted Cash Current | 0 | 0 | - | - | - | - | - | - | - | 1 | 0 | 1 | ||||||
Assets Current | ||||||||||||||||||
| Accounts Receivable Net Current | 1 | 0 | 0 | 0 | 10 | 1 | 1 | 0 | 1 | 7 | 1 | 1 | ||||||
| Assets Current | 60 | 81 | 93 | 107 | 133 | 147 | 139 | 168 | 140 | 147 | 130 | 149 | ||||||
| Assets Held For Sale Not Part Of Disposal Group Current | 2 | 2 | - | - | - | - | - | - | - | - | - | - | ||||||
| Prepaid Expense And Other Assets Current | 9 | 15 | 8 | 8 | - | 11 | - | - | - | - | - | - | ||||||
| Restricted Cash Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Property Plant And Equipment Net | 0 | 0 | 7 | 7 | 7 | 8 | 20 | 18 | 18 | 18 | 17 | 17 | ||||||
| Operating Lease Right Of Use Asset | 1 | 1 | 3 | 5 | 5 | 5 | 3 | 3 | 4 | 4 | 4 | 5 | ||||||
Assets Noncurrent | ||||||||||||||||||
| Assets Noncurrent | 1 | 2 | 17 | 18 | 13 | 14 | 25 | 23 | 23 | 23 | 22 | 23 | ||||||
| Finance Lease Right Of Use Asset | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Other Assets Noncurrent | - | - | - | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Prepaid Expense And Other Assets Noncurrent | 0 | 1 | 7 | 5 | - | 1 | - | - | - | - | - | - | ||||||
| Assets | 61 | 83 | 110 | 125 | 146 | 161 | 164 | 191 | 163 | 170 | 152 | 172 | ||||||
Liabilities And Stockholders Equity | ||||||||||||||||||
| Accounts Payable Current | 4 | 9 | 9 | 11 | 11 | 12 | 9 | 12 | 7 | 5 | 8 | 6 | ||||||
| Deferred Revenue Current | 4 | 5 | 5 | 4 | 5 | 15 | 16 | 20 | 19 | 16 | 8 | 10 | ||||||
Liabilities Current | ||||||||||||||||||
| Liabilities Current | 17 | 25 | 29 | 28 | 30 | 42 | 41 | 46 | 44 | 36 | 26 | 27 | ||||||
| Operating Lease Liability Current | 0 | 1 | 1 | 2 | 2 | 2 | 1 | 2 | 2 | 2 | 2 | 2 | ||||||
| Loans Payable Current | - | - | - | - | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | ||||||
| Loans Payable | - | - | - | - | - | - | - | - | - | 1 | 1 | 1 | ||||||
Liabilities Noncurrent | ||||||||||||||||||
| Liabilities Noncurrent | 11 | 7 | 9 | 11 | 12 | 29 | 28 | 33 | 35 | 32 | 12 | 13 | ||||||
| Operating Lease Liability Noncurrent | 0 | 0 | 2 | 3 | 3 | 4 | 1 | 2 | 2 | 2 | 2 | 3 | ||||||
| Deferred Revenue Noncurrent | 1 | 1 | 2 | 2 | 3 | 20 | 24 | 27 | 30 | 26 | 7 | 7 | ||||||
| Other Liabilities Noncurrent | 10 | 6 | 6 | 6 | 6 | 6 | 3 | 3 | 3 | 3 | 2 | 2 | ||||||
| Liabilities | 27 | 31 | 38 | 39 | 41 | 71 | 69 | 79 | 80 | 68 | 38 | 40 | ||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 469 | 469 | 468 | 467 | 467 | 467 | 446 | 445 | 398 | 397 | 396 | 395 | ||||||
Stockholders Equity | ||||||||||||||||||
| Stockholders Equity | 34 | 51 | 72 | 86 | 105 | 90 | 95 | 112 | 83 | 103 | 113 | 132 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -6 | -5 | -9 | -7 | -7 | -8 | -6 | -7 | -7 | -7 | -8 | -6 | ||||||
| Retained Earnings Accumulated Deficit | -428 | -413 | -388 | -374 | -355 | -369 | -344 | -325 | -307 | -288 | -275 | -257 | ||||||
| Liabilities And Stockholders Equity | 61 | 83 | 110 | 125 | 146 | 161 | 164 | 191 | 163 | 170 | 152 | 172 | ||||||
| Seriesa Convertible Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | ||||||
| Seriesa1 Convertible Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | - | - | ||||||
| Series A2 Convertible Preferred Stock | 0 | 0 | 0 | -0 | 0 | 0 | -0 | 0 | - | 0 | - | - | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | ||||||
| Common Stock Par Or Stated Value Per Share | - | - | - | 0.00 | - | - | - | - | - | - | - | - | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialHOOKIPA Pharma Inc. (HOOK) — SEC Financial Statements & Analysis
HOOKIPA Pharma Inc. (HOOK) is a pharmaceutical preparations company, incorporated in DE. HOOKIPA Pharma Inc. trades on OTC as: HOOK. HOOKIPA Pharma Inc. (HOOK)'s most recent SEC filing is a Form 10-Q for the period ended 2025-03-31, filed with the SEC on 2025-05-15. Based on that filing, On profitability, HOOKIPA Pharma Inc. posts a gross margin of 100.37%, an operating margin of -860.18%, a net margin of -784.01%, a Return on Equity (ROE) of -105.79%, a Return on Assets (ROA) of -70.79%, and a Return on Invested Capital (ROIC) of -9800.04%. Per share, it reports EPS of $-5.84, diluted EPS of $-5.84, free cash flow per share of $-4.21, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -82.54% year-over-year, net income growth of 54.29% year-over-year, and EPS growth of 54.21% year-over-year. On the balance sheet, it maintains a current ratio of 3.61x, a quick ratio of 3.07x, working capital of $43.45M, a debt-to-equity ratio of 0.80x, a debt ratio of 0.44, an interest coverage ratio of -20108.75x, free cash flow of $-52.87M (TTM), and net debt of $-40.48M. Figures sourced from SEC EDGAR.
- EPS TTM
- $-5.84
- ROE TTM
- -105.79%
- ROA TTM
- -70.79%
- Debt To Equity
- 0.80x
- Free Cash Flow TTM
- $-52.87M
- Net Revenue TTM Growth 1Y
- -82.54%
Data as of 2025-03-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is HOOKIPA Pharma Inc. in?
HOOKIPA Pharma Inc. (HOOK) operates in the Pharmaceutical Preparations industry.
What exchange does HOOK trade on?
HOOKIPA Pharma Inc. (HOOK) trades on the OTC.
Where is HOOKIPA Pharma Inc. incorporated?
HOOKIPA Pharma Inc. is incorporated in DE.
When was HOOKIPA Pharma Inc. (HOOK)'s most recent SEC filing?
HOOKIPA Pharma Inc. (HOOK)'s most recent SEC filing is a Form 10-Q for the period ended 2025-03-31, filed with the SEC on 2025-05-15.
What is HOOK's EPS (earnings per share)?
HOOKIPA Pharma Inc. (HOOK)'s trailing twelve month EPS is $-5.84 as of 2025-03-31.
What is HOOK's ROE (return on equity)?
HOOKIPA Pharma Inc. (HOOK)'s trailing twelve month Return on Equity (ROE) is -105.79% as of 2025-03-31.
What is HOOK's ROA (return on assets)?
HOOKIPA Pharma Inc. (HOOK)'s trailing twelve month Return on Assets (ROA) is -70.79% as of 2025-03-31.
What is HOOK's ROIC (return on invested capital)?
HOOKIPA Pharma Inc. (HOOK)'s trailing twelve month Return on Invested Capital (ROIC) is -9800.04% as of 2024-09-30.